Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 1:36 PM ISTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
Serdia Pharma launches nationwide campaign for angina awareness Medical Dialogues Bureau28 April 2019 9:25 AM ISTAs a part of this global initiative, SERDIA Pharmaceuticals has launched a comprehensive programme in India: 'Angina Awareness India'.New Delhi:...
Mylan launches generic Angiomax injection Ruby Khatun Khatun22 Jun 2018 10:15 AM ISTHERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Bivalirudin for Injection, 250 mg...